Gene cluster of pederin biosynthesis genes

Simple SummaryContent extracted from patent full text and abstract with AI.

This invention relates to the identification, cloning, and characterization of a specific gene cluster responsible for biosynthesis of pederin, a powerful anti-tumor compound. Uniquely, these genes are derived from unculturable bacterial symbionts living inside beetles. The patent covers the gene sequences, corresponding proteins, vectors, recombinant microbial production systems, and methods for producing pederin or its modified forms using biotechnology.

Use CasesContent extracted from patent full text and abstract with AI.

• Biotechnological production of pederin as a pharmaceutical anti-tumor agent via recombinant microorganisms instead of extraction from natural sources.
• Sustainable and scalable synthesis of pederin derivatives with potential improved anti-cancer properties.
• Synthetic biology applications for generating novel polyketide-based drugs inspired by the unique gene cluster architecture.
• Research tool for studying modular polyketide synthase/nonribosomal peptide synthetase biosynthesis.
• Platforms for combinatorial biosynthesis to access analogues of related marine-derived compounds.

BenefitsContent extracted from patent full text and abstract with AI.

• Provides a method to produce pederin independent of rare or unculturable natural sources, enabling sustainable, large-scale supply.
• Facilitates development of modified pederin derivatives with possibly improved therapeutic profiles.
• Introduces a new genetic architecture for polyketide synthesis, potentially allowing greater flexibility and engineering potential for novel drug development.
• Reduces ecological impact compared to harvesting beetles or marine sponges for natural compounds.
• Enables heterologous production of rare natural products in standard laboratory or industrial strains.

Technical Classifications (CPCs)

Inventors & Applicants

Patent Abstract

The present invention relates to the cloning, sequencing and analysing of a gene cluster encoding a modular polyketide synthase enzyme involved in the biosynthesis of the antitumor compound pederin. This novel cluster represents the first example of genes from an unculturable symbiont encoding the biosynthesis of a drug candidate.